Constipation: causes beyond diet and what your biomarkers can reveal

Thyroid dysfunction and slowed gut motility

Thyroid hormones regulate metabolic processes throughout the body, including the speed at which the gut contracts and moves contents through. Thyroid hormone receptors sit on intestinal smooth muscle cells, and when circulating thyroid hormones are insufficient, these cells become sluggish. The result is reduced peristalsis, extended gut transit time, and constipation that does not resolve with dietary changes because the underlying driver is hormonal. An underactive thyroid (hypothyroidism) is one of the most commonly overlooked causes of chronic constipation, particularly in women over 40. Constipation is one of the earliest symptoms of thyroid dysfunction, frequently appearing before TSH levels shift enough to register as clearly abnormal on standard testing. Standard TSH testing alone can miss cases where Free T3 (the active thyroid hormone) is low despite a borderline-normal TSH, because TSH reflects pituitary signalling rather than the hormone activity at the cell level.

Magnesium deficiency and impaired gut muscle function

Magnesium plays a direct role in muscle contraction throughout the body, including in the smooth muscle of the intestinal wall. Low magnesium reduces the strength and frequency of gut contractions, contributing to constipation. Magnesium also draws water into the large intestine osmotically, which softens stool and supports regular bowel movements. Serum magnesium is frequently within the normal range even when intracellular magnesium is low, because the body prioritises keeping blood magnesium stable by drawing from tissue stores. This means standard testing may not reveal functional magnesium insufficiency until the deficit is substantial. Dietary sources of magnesium include dark leafy greens, nuts, seeds, legumes, and dark chocolate.

Gut microbiome imbalance and methane-producing organisms

The gut microbiome influences bowel transit time through the gases and short-chain fatty acids produced during fermentation. Methane-producing microorganisms, in particular, are closely associated with constipation. Methane gas produced in the gut slows muscle contractions by binding to intestinal wall receptors, reducing the propulsive activity that moves stool forward. Research consistently shows that people with constipation-predominant gut symptoms have higher methane production and distinct microbiome profiles compared with those without constipation, including reduced populations of butyrate-producing bacteria that support gut motility and mucosal health. A gut microbiome test can identify whether the bacterial landscape is contributing to slowed transit.

The thyroid-microbiome feedback loop

The relationship between thyroid function and the gut microbiome is bidirectional, creating a feedback pattern that compounds constipation over time. Hypothyroidism reduces gut motility, which allows bacteria to accumulate in the small intestine (increasing SIBO risk) and shifts the microbiome composition toward less motility-supporting species. In turn, gut dysbiosis impairs the conversion of T4 to the active T3 hormone, which happens partly in the gut, further reducing thyroid activity. Breaking this cycle requires addressing both the thyroid and the microbiome rather than treating each in isolation.

Stress, cortisol, and the gut-brain axis

Chronic stress affects gut motility through the gut-brain axis. Elevated cortisol from sustained psychological stress suppresses intestinal motility and alters the gut microbiome over time. The enteric nervous system, which governs gut contractions, is exquisitely sensitive to stress signals from the brain via the vagus nerve. People under significant and prolonged stress often develop constipation that is resistant to dietary interventions because the driver is neurological and hormonal rather than nutritional. CRP testing reveals whether systemic inflammation is accompanying the stress and gut dysfunction pattern.

Medications that commonly cause constipation

Several widely used medications have constipation as a recognised side effect. Opioid pain medications are the most potent cause through their direct inhibition of gut motility receptors. Iron supplements commonly cause constipation by altering the gut microbiome and reducing intestinal fluid secretion. Calcium channel blockers used in blood pressure treatment, certain antihistamines, and some antidepressants all have constipating effects. Reviewing medication lists alongside biomarker testing provides a more complete picture of what is driving the pattern.

Structural and pelvic floor causes of chronic constipation

Structural causes including pelvic floor dysfunction, rectal prolapse, and anatomical variations in bowel anatomy can produce constipation that is unresponsive to dietary or hormonal treatment. These causes require assessment by a gastroenterologist or colorectal specialist and are outside the scope of biomarker testing. However, ruling out the systemic and hormonal causes described above is a reasonable first step in the investigation pathway, as they are considerably more prevalent than structural issues.

When constipation is persistent and dietary changes have not produced sustained improvement, a structured biomarker approach investigates the most common systemic drivers.

Thyroid markers are the highest-priority systemic investigation. A panel including TSH, Free T4, and Free T3 reveals whether thyroid function at the cell level is adequate, not just whether the pituitary is signalling normally. Anti-TPO antibodies identify autoimmune thyroid involvement (Hashimoto's thyroiditis) which may produce gut motility changes before TSH clearly shifts out of range.

Gut microbiome testing reveals the bacterial composition relevant to transit time and methane production. It identifies whether methane-associated microorganisms are elevated, whether butyrate-producing bacteria are reduced, and whether dysbiosis is contributing to the constipation pattern.

Ferritin, Vitamin D, Vitamin B12, and Magnesium through a blood panel reveal whether nutrient deficiencies are contributing, including nutritional patterns relevant to gut motility and muscle function.

A GP should be consulted if constipation is accompanied by blood in the stool, unexplained weight loss, or a significant change in bowel habit in someone over 45, as these warrant urgent clinical assessment.

Dietary fibre, types, and the microbiome response

Not all dietary fibre works the same way. Soluble fibre (from oats, apples, legumes, and flaxseed) absorbs water and forms a gel in the gut, softening stool and supporting the microbiome. Insoluble fibre (from wheat bran, kale, and whole grains) adds bulk and accelerates transit. Resistant starch, found in cooked and cooled potatoes and rice, feeds butyrate-producing bacteria that are often depleted in people with constipation. Increasing fibre intake should be gradual and accompanied by adequate fluid intake to prevent worsening of symptoms. Tracking bowel frequency alongside dietary changes provides objective evidence of whether a particular approach is working.

Hydration and gut transit

Water follows fibre into the large intestine, and insufficient fluid intake concentrates stool and slows transit. The commonly cited recommendation of 1.5 to 2 litres of water per day is a starting point, though individual needs vary with body size, activity level, and climate. Coffee has a known motility-stimulating effect through its influence on colonic contractions, which explains why many people have reliable morning bowel movements associated with their morning cup. Understanding individual responses to hydration and specific dietary components is part of the personalisation approach.

Movement, exercise, and gut motility

Physical activity has a direct and dose-dependent effect on gut transit time. Even moderate walking, 20 to 30 minutes daily, measurably reduces transit time in people with constipation. The mechanism involves both direct stimulation of intestinal contractions through core muscle activity and indirect effects through reduction of cortisol and improvement of gut microbiome diversity. People who become sedentary due to illness or lifestyle change commonly notice constipation emerging alongside reduced activity.

Supporting thyroid and nutrient status through diet

If thyroid function is identified as a contributing factor, optimising selenium and iodine intake is relevant because both are required for thyroid hormone production and the T4-to-T3 conversion. Selenium-rich foods include Brazil nuts (two per day typically meets the daily requirement), oily fish, and eggs. Dietary iodine is found in dairy, seafood, and iodised salt. Magnesium-rich foods that also support gut motility include dark leafy greens, pumpkin seeds, almonds, and dark chocolate. Tracking thyroid markers and magnesium status through regular retesting provides objective evidence of whether dietary changes are shifting the relevant biomarkers and whether the constipation pattern responds.